Therapeutic Response to Myosin Inhibitor Therapy in Noonan Syndrome-Associated Obstructive Hypertrophic Cardiomyopathy. [PDF]
Feidakis A +7 more
europepmc +1 more source
Cardiac Myosin Activators in Heart Failure: Experimental Advances Amid Clinical Uncertainty. [PDF]
Hou L, Lin B, Ji X, Huang A.
europepmc +1 more source
Impact of Mavacamten Approval on Septal Reduction Therapy Rates in Hypertrophic Cardiomyopathy. [PDF]
Ibrahim R +9 more
europepmc +1 more source
Emerging Role and Potential Therapeutic Application of TRIM Proteins in Cardiovascular Diseases. [PDF]
Cui Y, Wen Y, Wang X, Xu Y, Jiang M.
europepmc +1 more source
Emerging Pharmacological and Invasive Therapies for Hypertrophic Cardiomyopathy with Obstructive Physiology. [PDF]
Li-Wen Chu E, Seung Kim D, Masri A.
europepmc +1 more source
Advances in Non-Invasive Myocardial Stiffness Assessment and Clinical Applications in Hypertrophic Cardiomyopathy. [PDF]
Gao Y, Qi N, Gao H, Deng Y, Liu Y.
europepmc +1 more source
Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy During Active Chemotherapy. [PDF]
Caro-Codón J +9 more
europepmc +1 more source
A song of heads and tails: myosin II conformational regulation and filament dynamics shape force generation in non-muscle cells. [PDF]
Pérez-Díaz R +5 more
europepmc +1 more source
Editorial: Exploring molecular mechanisms and novel diagnostics in cardiovascular disease treatment. [PDF]
Sun J, Liu Y, Peng Q.
europepmc +1 more source

